Subscribe to our RSS feeds RSS | Login | Register  
 

Marketing Research Articles

Generics stall growth in prostate cancer market

Ben Comer July 01, 2008

Annual market growth in the prostate cancer drug market will slip to less than 2% through 2012, according to a new Pharmacor report.
 

MR giants merge to form GfK-TNS

Ben Comer July 01, 2008

GfK and TNS are moving forward on a "merger of equals," to be completed Q4, 2008, pending board approvals. The announcement was made June 3.
 

Vantage Point

Richard Vanderveer July 01, 2008

As pharmaceutical marketing researchers, we must be mindful that the federal government is not only involved in the regulation of the drug industry, but the 50 state governments are as well.
 

Obesity market set for huge growth

Matthew Arnold June 01, 2008

The market for obesity treatments will grow five-fold by 2016, according to research firm Decision Resources.
 

Pre-launch promotion crucial to brand strategy: Sanofi-Aventis marketing VP

Ben Comer June 01, 2008

Getting your brand noticed early in its lifespan is crucial to pharma product position strategy said, Corinne Le Goff, VP, marketing, at Sanofi-Aventis.
 

Vantage Point

Richard Vanderveer June 01, 2008

We are witnessing the death of pharma marketing research and the birth of healthcare marketing research.
 

TNS Healthcare launches DetailMed

Ben Comer May 01, 2008

TNS Healthcare has unveiled a call assessment tool measuring detail effectiveness across countries, brands and categories.
 

'08 Senior Health Digest finds less trust in Rx ads

Ben Comer May 01, 2008

Eisai unveiled its 2008 Senior Health Digest at the Academy of Managed Care Pharmacy's 20th Annual Meeting & Showcase, in April.
 

Vantage Point

Richard Vanderveer May 01, 2008

I recently attended the PMRG conference in Phoenix, and came away with several realizations.
 

Pharma wants partners not just data suppliers

James Chase April 01, 2008

Form true partnerships with your clients, keep them happy and make your recommendations short and sweet—that's the message from pharma companies to their marketing research suppliers and consultants, according to a new study by marketRx, a Cognizant Company.